InvestorsHub Logo
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

Re: None

Friday, 02/22/2019 9:27:53 PM

Friday, February 22, 2019 9:27:53 PM

Post# of 1109
A drug that instance relieve migraine headaches better than the over the counter or prescription headache drug that already on the market. This company should be worth at least 500 million dollar market cap. I give it less than 2 weeks from now some big pharma will offer $20 a share before FDA approve Zosano Pharma Corp drug for the treatment of migraine suffers.

This is sure big money for all shareholders invested in Zosano Pharma Corp. My point of view make sure I'am in when news is release because they could do the same thing SRPT did with their new drug before it was approve on great news like Zosano received yesterday. If big pharma think this drug has a big chance of getting an FDA approval they will be all over this one before their competitors grab this gem.

Company just release the great news yesterday the drug has met all its primary long term study endpoint with high positive data and safety requirement met, imo this as good as sold to the highest offer bidder. All the big pharma now know about Zosano migraine suffer drug, the company has been put on the map big time yesterday.

Fellas we're about to get paid.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.